Mangoceuticals, Inc.
MGRX
$4.91
-$0.37-7.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -94.02% | -83.37% | -99.60% | 8.21% | 41.58% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -38.89% | -40.43% | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 421.37% | 305.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -74.81% | -- | -- | -- |
| Total Current Assets | -92.25% | -82.88% | -97.65% | 17.84% | 50.14% |
|
|
|||||
| Total Current Assets | -92.25% | -82.88% | -97.65% | 17.84% | 50.14% |
| Net Property, Plant & Equipment | -66.94% | -16.73% | -29.43% | -26.16% | 9,336.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -708.88% | 0.00% | 0.00% | 0.00% |
| Total Assets | 827.11% | 362.23% | -92.68% | 4.73% | 74.62% |
|
|
|||||
| Total Accounts Payable | 746.24% | 452.00% | 3,312.01% | 317.80% | -- |
| Total Accrued Expenses | -31.71% | -22.95% | 86.36% | 144.44% | 1,071.43% |
| Short-term Debt | -- | -- | -1.91% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.95% | 11.96% | 12.33% | 12.35% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 773.99% | 601.42% | 563.13% | -18.99% | 77.09% |
|
|
|||||
| Total Current Liabilities | 773.99% | 601.42% | 563.13% | -18.99% | 77.09% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -1.91% | -- | -- |
| Capital Leases | -85.03% | -69.10% | -57.90% | -49.49% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 483.09% | 379.21% | 325.50% | -29.10% | 167.74% |
|
|
|||||
| Common Stock & APIC | 215.46% | 207.23% | 50.52% | 356.42% | 362.37% |
| Retained Earnings | -107.69% | -133.02% | -197.07% | -457.01% | -545.26% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 888.28% | 360.58% | -125.09% | 26.19% | 64.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 888.28% | 360.58% | -125.09% | 26.19% | 64.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 888.23% | 360.57% | -125.10% | 26.19% | 64.44% |
|
|
|||||
